Document:

Exhibit 10.6

 

EXECUTION VERSION

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT
(as the same may be amended, supplemented, restated or otherwise modified from time to time in accordance with the terms hereof, this
 “Agreement”), dated as of June 3, 2021, is made and entered into by and among:

 

(i) Babylon
Holdings Limited, a company limited by shares incorporated under the laws of Jersey with registered number 115471
(“Company” or “Pubco”);

 

(ii)Alkuri Sponsors LLC
(the “Sponsor”); and

 

(iii) certain shareholders
of Company, as set forth on Schedule A hereto (the “Legacy Equityholders” and, together with the Sponsor and
any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder”
and, collectively the “Holders”).

 

Capitalized terms used but not
defined herein shall have the meanings ascribed to them in the Merger Agreement.

 

RECITALS

 

WHEREAS, contemporaneously
with the execution and delivery of this Agreement, Alkuri Global Acquisition Corp. (“SPAC”) and Company are entering
into that certain Agreement and Plan of Merger, dated as of June 3, 2021 (the “Merger Agreement”) with Liberty USA
Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of Company (“Merger Sub”), whereby, among
other things, Merger Sub will merge with and into the SPAC (the “Merger”) at the Effective Time, whereupon the separate
existence of Merger Sub will cease, and SPAC will continue as the surviving company (the “Surviving Company”); and

 

WHEREAS, pursuant to the terms
and provisions of the Merger Agreement, prior to the effective time of the Merger (the “Effective Time”), Company will
have undertaken the Recapitalization whereby, among other things, (i) ordinary shares of the Company held by the Legacy Equityholders
will be reclassified into class A ordinary shares and class B ordinary shares, and (ii) the Company will adopt an amended and restated
Memorandum and Articles of Association in the form attached to the Merger Agreement as Exhibit B (the “Amended and Restated Memorandum
and Articles of Association”); and

 

WHEREAS, following the consummation
of the Merger, (i) the Sponsor and certain Legacy Equityholders will beneficially own Pubco Class A Shares, and (ii) the Founder will
beneficially own Pubco Class A Shares and Pubco Class B Shares; and

 

WHEREAS, in anticipation of
the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), SPAC, the Company and the
Holders desire to enter into this Agreement on the date hereof, to be effective upon the Closing, pursuant to which the Company shall
grant the Holders certain registration rights with respect to the Registrable Securities (as defined herein) on the terms and conditions
set forth in this Agreement.

 

NOW, THEREFORE, in consideration
of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

     

     

    

 

Article
I

DEFINITIONS

 

1.1
     Definitions. The terms defined in this Article I shall, for all purposes
of this Agreement, have the respective meanings set forth below:

 

“Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith
judgment of the Chief Executive Officer of the Company or the Board, after consultation with counsel to the Company, (i) would be
required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not
to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein
(in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading,
(ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used,
as the case may be, and (iii) the Company has a bona fide business purpose for not making such information public.

 

“Action”
shall mean any demand, action, claim, suit, countersuit, arbitration, inquiry, subpoena, case, litigation, proceeding or investigation
(whether civil, criminal, administrative or investigative) by or before any court or grand jury, any Governmental Authority or any arbitration
or mediation tribunal.

 

“Affiliate”
shall have the meaning given in the Merger Agreement.

 

“Agreement”
shall have the meaning given in the Preamble hereto.

 

“Amended and Restated
Memorandum and Articles of Association” shall have the meaning given in the Recitals hereto.

 

“Board”
shall mean the board of directors of the Company.

 

“Blackout Period”
shall have the meaning given in Section 3.4.2.

 

“Block Trade”
shall mean an offering and/or sale of Registrable Securities by any Holder on a block trade or underwritten basis (whether firm commitment
or otherwise) without substantial marketing efforts prior to pricing, including, without limitation, a same day trade, overnight trade
or similar transaction.

 

“Memorandum and Articles
of Association” shall mean the Memorandum and Articles of Association of the Company in effect immediately prior to the adoption
of the Amended and Restated Memorandum and Articles of Association.

 

“Closing”
shall have the meaning given in the Recitals hereto.

 

“Closing
Date” shall have the meaning given in the Merger Agreement.

 

“Commission”
shall mean the Securities and Exchange Commission.

 

“Company”
shall have the meaning given in the Recitals hereto and includes the Company’s successors by recapitalization, merger, consolidation,
spin-off, reorganization or similar transaction.

 

“Demanding Holder”
shall have the meaning given in Section 2.1.4.

 

    2

     

    

 

“Earnout Shares”
shall have the meaning given in the Merger Agreement.

 

“Effective Time”
shall have the meaning given in the Recitals hereto.

 

“Exchange
Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

 

“FINRA”
shall mean the Financial Industry Regulatory Authority Inc.

 

“Form
F-1 Shelf” shall have the meaning given in Section 2.1.1.

 

“Form
F-3 Shelf” shall have the meaning given in Section 2.1.1.

 

“Governmental Authority”
shall mean any federal, state, provincial, municipal, local or foreign government, governmental authority, regulatory or administrative
agency (which for the purposes of this Agreement shall include FINRA and the Commission), governmental commission, department, board,
bureau, agency or instrumentality, arbitral panel, court or tribunal, whether domestic, foreign, multinational, or supranational exercising
executive, legislative, judicial, regulatory, self-regulatory or administrative functions of or pertaining to government and any executive
official thereof.

 

“Governmental Order”
means any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case, entered by or with any Governmental
Authority.

 

“Holder”
and “Holders” shall have the meaning given in the Preamble hereto, for so
long as such person or entity holds any Registrable Securities.

 

“Holder Information”
shall have the meaning given in Section 4.1.2.

 

“Law” shall
mean any applicable U.S. or non-U.S. federal, national, supranational, state, provincial, local or similar statute, law, ordinance, regulation,
rule, code, income Tax treaty, Governmental Order, requirement or rule of law (including common law) or other binding directives promulgated,
issued, entered into or taken by any Governmental Authority.

 

“Legacy Equityholders”
shall have the meaning given in the Preamble hereto.

 

“Lockup Agreement”
shall have the meaning given in the Merger Agreement.

 

“Lockup Period”
shall have the meaning given in the applicable Lockup Agreement.

 

“Major Legacy Equityholder”
shall mean each of (i) Ali Parsadoust, ALP Limited Partners and the Parsa Family Foundation, together as a group with their Permitted
Transferees, (ii) Kinnevik Online AB, together with its Permitted Transferees, (iii) VNV (Cyprus) Limited and Global Health Equity (Cyprus)
Limited, together as a group with its Permitted Transferees and (iv) The Public Investment Fund, together with its Permitted Transferees,
and together (i)-(iv), the “Major Legacy Equityholders.”

 

“Maximum Number of
Securities” shall have the meaning given in Section 2.1.5.

 

“Merger”
shall have the meaning given in the Recitals hereto.

 

“Merger Agreement”
shall have the meaning given in the Recitals hereto.

 

“Merger Sub”
shall have the meaning given in the Recitals hereto.

 

    3

     

    

 

“Minimum Takedown
Threshold” shall have the meaning given in Section 2.1.4.

 

“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light
of the circumstances under which they were made) not misleading.

 

“New Registration
Statement” shall have the meaning given in Section 2.1.7.

 

“Other Coordinated
Offering” shall have the meaning given in Section 2.4.1.

 

“Permitted
Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such
Registrable Securities prior to the expiration of the Lockup Period pursuant to the Amended and Restated Memorandum and Articles of Association
and the Lockup Agreements to which such Holder is a party.

 

“Person”
shall have the meaning given in the Merger Agreement.

 

“Piggyback Registration”
shall have the meaning given in Section 2.2.1.

 

“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“Pubco Class A Shares”
means, after the Reclassification, the Class A ordinary shares of no par value of Company, having the rights and being subject the restrictions,
set out in the Amended and Restated Memorandum and Articles of Association.

 

“Pubco Class B Shares”
means, after the Reclassification, the Class B ordinary shares of no par value of Company, having the rights and being subject the restrictions,
set out in the Amended and Restated Memorandum and Articles of Association.

 

“Pubco Shares”
shall mean, individually and collectively, all equity securities of the Company, including, without limitation, the Pubco Class A Shares
and the Pubco Class B Shares.

 

“Reclassification”
shall have the meaning given in the Merger Agreement.

 

“Registrable
Security” shall mean (a) any outstanding Pubco Shares held by a Holder immediately following the Closing (including
any Pubco Shares issued in connection with the Reclassification, or issued or issuable in connection with the Merger pursuant to the
terms of the Merger Agreement), (b) any Pubco Shares issued or issuable upon the conversion or exchange of any other class of Pubco Shares
following the Closing in accordance with the Amended and Restated Memorandum and Articles of Association, (c) any warrants or Pubco Shares
that may be acquired by Holders upon the exercise of a warrant or other right to acquire Pubco Shares held by a Holder immediately following
the Closing, (d) any Pubco Shares or warrants to purchase Pubco Shares (including any Pubco Shares issued or issuable upon the exercise
of any such warrant) of the Company otherwise acquired or owned by a Holder following the date hereof to the extent that such securities
are “restricted securities” (as defined in Rule 144) or are otherwise held by an “affiliate” (as defined in Rule
144) of the Company, (e) any Earnout Shares issued or issuable to a Holder following the Closing, and (f) any other equity security
of the Company or any of its subsidiaries issued or issuable with respect to any securities referenced in clause (a), (b), (c), (d) or
(e) above by way of a stock dividend or stock split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization
or similar transaction; provided, however, that, as to any particular Registrable Security, such security shall cease to
be a Registrable Security upon the earliest to occur of: (A) the transfer of such security by a Holder to any Person other than
(i) an Affiliate or equityholder of such Holder, (ii) a lender pursuant to a bonafide pledge of such Registrable Securities or (iii)
another Holder or an Affiliate or equityholder of such other Holder; (B) the time at which such security ceases to be outstanding;
and (C) upon the sale of such security to, or through, a broker, dealer or underwriter in a public distribution or other public
securities transaction.

 

    4

     

    

 

“Registration”
shall mean a registration effected by preparing and filing a registration statement, prospectus or similar document in compliance with
the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement
becoming effective.

 

“Registration
Expenses” shall mean the expenses of a Registration, including, without limitation, the following:

 

(A) all registration and
filing fees (including fees with respect to filings required to be made with FINRA) and any national securities exchange on which
the Pubco Shares are then listed;

 

(B) fees and expenses of
compliance with securities or blue sky laws (including reasonable fees and disbursements of outside counsel for the Underwriters in
connection with blue sky qualifications of Registrable Securities);

 

(C) printing, messenger,
telephone and delivery expenses;

 

(D) fees and
disbursements of counsel for the Company, one counsel for the Underwriters (if applicable) and one counsel for the selling Holders
(selected by the Demanding Holder or, if none, by a majority-in-interest of the participating Holders);

 

(E) fees and
disbursements of all independent registered public accountants of the Company incurred specifically in connection with such
Registration; and

 

(F) reasonable fees and
expenses of one legal counsel selected by the majority-in-interest of the securities requested to be registered by the Demanding
Holders in an Underwritten Offering (not to exceed $50,000 without the consent of the Company).

 

“Registration
Statement” shall mean any registration statement that covers Registrable Securities pursuant to the provisions of this
Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements
to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Requesting Holders”
shall have the meaning given in Section 2.1.5.

 

“SEC Guidance”
shall have the meaning given in Section 2.1.7.

 

“Securities
Act” shall mean the Securities Act of 1933, as amended from time to time.

 

“Shelf”
shall mean the Form F-1 Shelf, the Form F-3 Shelf or any Subsequent Shelf Registration, as the case may be.

 

    5

     

    

 

“Shelf Registration”
shall mean a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant
to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).

 

“SPAC”
shall have the meaning given in the Preamble hereto.

 

“Sponsor”
shall have the meaning given in the Preamble hereto.

 

“Subsequent Shelf
Registration” shall have the meaning given in Section 2.1.2.

 

“Transfer”
shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with respect to, any security,
(b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement
of any intention to effect any transaction specified in clause (a) or (b).

 

“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal and not as part of such dealer’s market-making
activities.

 

“Underwritten Offering”
shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution
to the public.

 

“Underwritten Shelf
Takedown” shall have the meaning given in Section 2.1.4.

 

“Withdrawal Notice”
shall have the meaning given in Section 2.1.6.

 

Article
II

REGISTRATIONS AND OFFERINGS

 

2.1              
Shelf Registration.

 

2.1.1         
Filing. The Company shall file within 30 days of the Closing Date, and use commercially reasonable efforts to cause
to be declared effective as soon as practicable thereafter, a Registration Statement for a Shelf Registration on Form F-1 or Form S-1,
as applicable (the “Form F-1 Shelf”) or, if the Company is eligible to use a Registration Statement on Form F-3 or
Form S-3, a Shelf Registration on Form F-3 or Form S-3, as applicable (the “Form F-3 Shelf”), in each case, covering
the resale of all the Registrable Securities (determined as of two business days prior to such filing) on a delayed or continuous basis.
Such Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods
legally available to, and requested by, any Holder named therein. The Company shall maintain a Shelf in accordance with the terms hereof,
and shall prepare and file with the SEC such amendments, including post-effective amendments, and supplements as may be necessary to keep
a Shelf continuously effective, available for use and in compliance with the provisions of the Securities Act until such time as there
are no longer any Registrable Securities. In the event the Company files a Form F-1 Shelf, the Company shall use its commercially reasonable
efforts to convert the Form F-1 Shelf (and any Subsequent Shelf Registration) to a Form F-3 Shelf as soon as practicable after the Company
is eligible to use Form F-3.

 

    6

     

    

 

2.1.2         
Subsequent Shelf Registration. If any Shelf ceases to be effective under the Securities Act for any reason at any
time while Registrable Securities are still outstanding, the Company shall, subject to Section 3.4, use its commercially reasonable
efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act (including obtaining
the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as
promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending
the effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a “Subsequent Shelf Registration”)
registering the resale of all Registrable Securities (determined as of two business days prior to such filing), and pursuant to any method
or combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is filed,
the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective under the
Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration
shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a well-known
seasoned issuer (as defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination
date), and (ii) keep such Subsequent Shelf Registration continuously effective, available for use and in compliance with the provisions
of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall
be on Form F-3 or Form S-3, as applicable, to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf
Registration shall be on another appropriate form.

 

2.1.3         
Additional Registerable Securities. In the event that any Holder holds Registrable Securities that are not registered
for resale on a delayed or continuous basis, the Company, upon written request of the Sponsor, shall promptly use its commercially reasonable
efforts to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, any then available
Shelf (including by means of a post-effective amendment) or by filing a Subsequent Shelf Registration and cause the same to become effective
as soon as practicable after such filing and such Shelf or Subsequent Shelf Registration shall be subject to the terms hereof.

 

2.1.4         
Requests for Underwritten Shelf Takedowns. At any time and from time to time when an effective Shelf is on file with
the Commission, (i) the Sponsor (or any lender to the Sponsor who receives Registrable Securities as a result of a foreclosure of Sponsor’s
pledge on such securities) or (ii) any Major Legacy Equityholder (being, in such case, a “Demanding Holder”) may request
to sell all or any portion of its Registrable Securities in an Underwritten Offering or other coordinated offering that is registered
pursuant to the Shelf (each, an “Underwritten Shelf Takedown”); provided, that the Company shall only be obligated
to effect an Underwritten Shelf Takedown if such offering shall include Registrable Securities proposed to be sold by all Holders selling
any Registrable Securities in such offering with a total offering price reasonably expected to exceed, in the aggregate, $30 million (the
 “Minimum Takedown Threshold”); and each Demanding Holder shall be permitted to request three Underwritten Shelf Takedowns
per calendar year. All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company, which shall specify
the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown. Subject to Section 2.4.4,
the Demanding Holder shall have the right to select the Underwriters for such offering (which shall consist of one or more reputable nationally
recognized investment banks), subject to the Company’s prior approval (which shall not be unreasonably withheld, conditioned or
delayed).

 

2.1.5         
Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown,
in good faith, advises the Company, the Demanding Holder and the Holders requesting piggy back rights pursuant to this Agreement with
respect to such Underwritten Shelf Takedown (the “Requesting Holders”) (if any) in writing that the dollar amount or
number of Registrable Securities that the Demanding Holder and the Requesting Holders (if any) desire to sell, taken together with all
other Pubco Shares or other equity securities that the Company desires to sell and all other Pubco Shares or other equity securities,
if any, that have been requested to be sold in such Underwritten Offering pursuant to separate written contractual piggy-back registration
rights held by any other shareholders, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the
Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability
of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number
of Securities”), then the Company shall include in such Underwritten Offering, before including any Pubco Shares or other equity
securities proposed to be sold by Company or by other holders of Pubco Shares or other equity securities, the Registrable Securities of
the Demanding Holder and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that such
Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Shelf Takedown and the aggregate number
of Registrable Securities that the Demanding Holder and Requesting Holders have requested be included in such Underwritten Shelf Takedown)
that can be sold without exceeding the Maximum Number of Securities.

 

    7

     

    

 

2.1.6         
Withdrawal. Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used
for marketing such Underwritten Shelf Takedown, the Demanding Holder initiating an Underwritten Shelf Takedown shall have the right to
withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a “Withdrawal Notice”)
to the Company and the Underwriter or Underwriters (if any) of its intention to withdraw from such Shelf Takedown, and such Underwritten
Shelf Takedown shall not be counted as a demand for an Underwritten Shelf Takedown under Section 2.1.4 hereof; provided that the
Requesting Holders may elect to have the Company continue an Underwritten Shelf Takedown if the Minimum Takedown Threshold would still
be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown. Following the receipt of any Withdrawal
Notice, the Company shall promptly forward such Withdrawal Notice to any other Holders that had elected to participate in such Shelf Takedown.
Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in
connection with a Shelf Takedown prior to its withdrawal under this Section 2.1.6. Notwithstanding anything to the contrary in
this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Shelf Takedown prior to its
withdrawal under this Section 2.1.6.

 

2.1.7         
New Registration Statement. Notwithstanding the registration obligations set forth in this Section 2.1, in
the event the Commission informs the Company that the Registrable Securities cannot, as a result of the application of Rule 415, be registered
for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each of the holders thereof
and file amendments to the Shelf Registration as required by the Commission and/or (ii) withdraw the Shelf Registration and file a new
registration statement (a “New Registration Statement”), on Form F-3 or Form S-3, as applicable, or if such forms are
not then available to the Company for such registration statement, on such other form available to register for resale of the Registrable
Securities as a secondary offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company
shall advocate with the Commission for the registration of all of the Registrable Securities in accordance with any publicly-available
written or oral guidance, comments, requirements or requests of the Commission staff (“SEC Guidance”), including without
limitation, the Manual of Publicly Available Telephone Interpretations D.29. Notwithstanding any other provision of this Agreement, if
any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company advocated with the Commission for the registration of all or a
greater number of Registrable Securities), unless otherwise directed in writing by a holder as to its Registrable Securities, the number
of Registrable Securities to be registered on such Registration Statement will be reduced on a pro rata basis based on the total number
of Registrable Securities held by the Holders, subject to a determination by the Commission that certain Holders must be reduced first
based on the number of Registrable Securities held by such Holders. In the event the Company amends the Shelf Registration or files a
New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will file with the Commission, as promptly
as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration
statements on Form F-3, Form S-3, or such other form available to register for resale those Registrable Securities that were not registered
for resale on the Shelf Registration, as amended, or the New Registration Statement.

 

    8

     

    

 

2.1.8         
Effective Registration. Notwithstanding the provisions of Sections 2.1.3 or 2.1.4 above or any other
part of this Agreement, a Registration shall not count as a Registration unless and until (i) the Registration Statement has been declared
effective by the Commission, and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto;
provided, however, that, if after such Registration Statement has been declared effective, an offering of Registrable Securities
is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency
the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i)
such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders
initiating such Registration thereafter affirmatively elect to continue with such Registration and accordingly notify the Company in writing,
but in no event later than five (5) days, of such election; provided, further, that the Company shall not be obligated or
required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration
pursuant to a Demand Registration becomes effective or is subsequently terminated.

 

2.2              
Piggyback Registration.

 

2.2.1         
Piggyback Rights. Subject to Section 2.4.3, if the Company or any Holder proposes to conduct a registered
offering of, or if the Company proposes to file a Registration Statement under the Securities Act with respect to the Registration of,
equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its
own account or for the account of shareholders of the Company (or by the Company and by the shareholders of the Company including, without
limitation, an Underwritten Shelf Takedown pursuant to Section 2.1 hereof), other than a Registration Statement (or any registered
offering with respect thereto) (i) filed in connection with any employee stock option or other benefit plan, (ii) pursuant to a Registration
Statement on Form F-4 or Form S-4 (or other similar form that relates to a transaction subject to Rule 145 under the Securities Act or
any successor rule thereto), (iii) for an offering of debt that is convertible into equity securities of the Company, (iv) for a dividend
reinvestment plan, or (v) for a rights offering, then the Company shall give written notice of such proposed offering to all of the Holders
of Registrable Securities as soon as practicable but not less than 10 days before the anticipated filing date of such Registration Statement
or, in the case of an Underwritten Offering pursuant to a Shelf Registration, the applicable “red herring” prospectus or prospectus
supplement used for marketing such offering, which notice shall (A) describe the amount and type of securities to be included in such
offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering,
and (B) offer to all of the Holders of Registrable Securities the opportunity to include in such registered offering such number of Registrable
Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such registered offering,
a “Piggyback Registration”). Subject to Section 2.2.2, the Company shall, in good faith, cause such Registrable
Securities to be included in such Piggyback Registration and, if applicable, shall use its commercially reasonable efforts to cause the
managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant
to this Section 2.2.1 to be included therein on the same terms and conditions as any similar securities of the Company included
in such registered offering and to permit the sale or other disposition of such Registrable Securities in accordance with the intended
method(s) of distribution thereof. The inclusion of any Holder’s Registrable Securities in a Piggyback Registration shall be subject
to such Holder’s agreement to enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten
Offering.

 

    9

     

    

 

2.2.2         
Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Offering that
is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback
Registration in writing that the dollar amount or number of the Pubco Shares or other equity securities that the Company desires to sell,
taken together with (i) the Pubco Shares or other equity securities, if any, as to which Registration or a registered offering has been
demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities
hereunder, (ii) the Registrable Securities as to which registration has been requested pursuant to Section 2.2 hereof, and (iii)
the Pubco Shares or other equity securities, if any, as to which Registration or a registered offering has been requested pursuant to
separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities,
then:

 

(a)               
if the Registration or registered offering is undertaken for the Company’s account, the Company shall include in any
such Registration or registered offering (A) first, the Pubco Shares or other equity securities that the Company desires to sell, which
can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not
been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable
Securities pursuant to Section 2.2.1, pro rata, based on the respective number of Registrable Securities that each Holder
has requested be included in such Underwritten Offering and the aggregate number of Registrable Securities that the Holders have requested
to be included in such Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to
the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Pubco Shares or other
equity securities, if any, as to which Registration or a registered offering has been requested pursuant to written contractual piggy-back
registration rights of persons or entities other than the Holders of Registrable Securities hereunder;

 

(b)               
if the Registration or registered offering is pursuant to a request by persons or entities other than the Holders of Registrable
Securities, then the Company shall include in any such Registration or registered offering (A) first, the Pubco Shares or other equity
securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without
exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under
the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant
to Section 2.2.1, pro rata, based on the respective number of Registrable Securities that each Holder has requested be included
in such Underwritten Offering and the aggregate number of Registrable Securities that the Holders have requested to be included in such
Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum
Number of Securities has not been reached under the foregoing clauses (A) and (B), the shares of Pubco Shares or other equity securities
that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent
that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the shares of Pubco Shares or
other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate written
contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities; and

 

(c)               
if the Registration or registered offering is pursuant to a request by Holder(s) of Registrable Securities pursuant to Section
2.1 hereof, then the Company shall include in any such Registration or registered offering securities in the priority set forth in
Section 2.1.5.

 

    10

     

    

 

2.2.3         
Piggyback Registration Withdrawal. Any Holder of Registrable Securities (other than the Demanding Holder, whose right
to withdrawal from an Underwritten Shelf Takedown, and related obligations, shall be governed by Section 2.1.6) shall have the
right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter
or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration
Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to
a Shelf Registration, the filing of the applicable “red herring” prospectus or prospectus supplement with respect to such
Piggyback Registration used for marketing such transaction. The Company (whether on its own good faith determination or as the result
of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed
with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall include the Shelf) at any time prior
to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than Section
2.1.6), the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior
to its withdrawal under this Section 2.2.3.

 

2.2.4         
Unlimited Piggyback Registration Rights. For purposes of clarity, subject to Section 2.1.6, any Piggyback
Registration effected pursuant to Section 2.2 hereof shall not be counted as a demand for an Underwritten Shelf Takedown under
Section 2.1.4 hereof.

 

2.3              
Market Stand-off. In connection with any Underwritten Offering of equity securities of the Company (other than a
Block Trade or Other Coordinated Offering), each Holder given an opportunity to participate in the Underwritten Offering pursuant to the
terms of this Agreement agrees that it shall not initiate a new Transfer any Pubco Shares or other equity securities of the Company (other
than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the 90-day
period beginning on the date of pricing of such offering or such shorter period during which the Company agrees not to conduct an underwritten
primary offering of Pubco Shares, except (i) in the event the Underwriters managing the offering otherwise agree by written consent and
(ii) Rule 10b5-1 trading plans (or similar plan) in effect prior to such 90-day period. Each Holder agrees to execute a customary lock-up
agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions as all such Holders).

 

2.4              
Block Trades; Other Coordinated Offerings.

 

2.4.1         
Notwithstanding any other provision of Article II, but subject to Sections 2.3 and 3.4, at any time and from
time to time when an effective Shelf is on file with the Commission and effective, if a Demanding Holder wishes to engage in (a) a Block
Trade or (b) an “at the market” or similar registered offering through a broker, sales agent or distribution agent, whether
as agent or principal (an “Other Coordinated Offering”), in each case with a total offering price reasonably expected to exceed,
in the aggregate, either the lesser of (x) $10 million and (y) all remaining Registrable Securities held by the Demanding Holder, then
notwithstanding the time periods provided for in Section 2.1.4, such Demanding Holder shall notify the Company of the Block Trade
or Other Coordinated Offering at least five (5) business days prior to the day such offering is to commence and the Company shall as expeditiously
as possible use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding
Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall
use commercially reasonable efforts to work with the Company and any Underwriters or placement agents or sales agents prior to making
such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to
the Block Trade or Other Coordinated Offering and any related due diligence and comfort procedures, in accordance with Sections 3.1.11
and 3.1.12.

 

    11

     

    

 

2.4.2         
Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with
a Block Trade or Other Coordinated Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated
Offering shall have the right to submit a Withdrawal Notice to the Company and the Underwriter or Underwriters or placement agents or
sales agents (if any) of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to
the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade
or Other Coordinated Offering prior to its withdrawal under this Section 2.4.2.

 

2.4.3         
Any Registration effected pursuant to this Section 2.4 shall be deemed an Underwritten Shelf Takedown and within
the cap on Underwritten Shelf Takedowns provided in the last sentence of Section 2.1.4. Notwithstanding anything to the contrary
in this Agreement, Section 2.2 hereof shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder
pursuant to this Agreement.

 

2.4.4         
The Company shall have the right to consent to the Underwriters and any sale agents or placement agents (if any) for such
Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally recognized investment
banks), which consent will not be unreasonably withheld, conditioned or delayed.

 

Article
III

COMPANY PROCEDURES

 

3.1              
General Procedures. In connection with any Shelf and/or Shelf Takedown, the Company
shall use its commercially reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance
with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

 

3.1.1         
prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities
and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable
Securities have ceased to be Registrable Securities;

 

3.1.2         
prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such
supplements to the Prospectus, as may be reasonably requested by any Holder that holds at least five (5.0%) percent of the Registrable
Securities registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations
thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold
in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

 

3.1.3         
prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to
the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel,
copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case
including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement
(including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included
in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities
owned by such Holders;

 

    12

     

    

 

3.1.4         
prior to any public offering of Registrable Securities (i) register or qualify the Registrable Securities covered by the
Registration Statement under such securities or “blue sky” laws of such jurisdictions
in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan
of distribution) may request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration
or qualification) and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be
registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the
Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included
in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;

 

3.1.5         
cause all such Registrable Securities to be listed on each national securities exchange on which similar securities issued
by the Company are then listed;

 

3.1.6         
provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than
the effective date of such Registration Statement;

 

3.1.7         
advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of
the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening
of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain
its withdrawal if such stop order should be issued;

 

3.1.8         
at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to
such Registration Statement or Prospectus (or such shorter period of time as may be necessary in order to comply with the Securities Act,
the Exchange Act, and the rules and regulations promulgated under the Securities Act or Exchange Act, as applicable), furnish a copy thereof
to each seller of such Registrable Securities or its counsel (excluding any exhibits thereto and any filing made under the Exchange Act
that is to be incorporated by reference therein);

 

3.1.9         
notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under
the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then
in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

 

3.1.10     
permit a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders
or Underwriter to participate, in the preparation of the Registration Statement, and cause the Company’s officers, directors and
employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection
with the Registration; provided, however, that such representatives or Underwriters agree to confidentiality arrangements
reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

 

3.1.11     
obtain a “comfort” letter from the Company’s independent registered public accountants in the event of
an Underwritten Offering, Block Trade or other Coordinated Offering that is registered pursuant to a Registration Statement, in customary
form and covering such matters of the type customarily covered by “comfort” letters as the managing Underwriter or other similar
type of sales agent or placement agent may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating
Holders;

 

    13

     

    

 

3.1.12     
on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such
date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales
agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion
is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in
such opinions and negative assurance letters, and reasonably satisfactory to a majority-in-interest of the participating Holders;

 

3.1.13     
in the event of any Underwritten Offering or other coordinated offering that is registered pursuant to a Registration Statement,
enter into and perform its obligations under an underwriting agreement, sales agreement or placement agreement, in usual and customary
form, with the managing Underwriter, sales agent or placement agent of such offering;

 

3.1.14     
make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of
at least 12 months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule then in
effect);

 

3.1.15     
if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $30 million
with respect to an Underwritten Offering pursuant to Section 2.1.4, use its reasonable efforts to make available senior executives
of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in
such Underwritten Offering;

 

3.1.16     
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the
Holders, in connection with such Registration; and

 

3.1.17     
upon request of a Holder, the Company shall (i) authorize the Company’s transfer agent to remove any legend on share
certificates of such Holder’s Pubco Shares restricting further transfer (or any similar restriction in book entry positions of such
Holder) if such restrictions are no longer required by the Securities Act or any applicable state securities laws or any agreement with
the Company to which such Holder is a party, including if such shares subject to such a restriction have been sold on a Registration Statement,
(ii) request the Company’s transfer agent to issue in lieu thereof Pubco Shares without such restrictions to the Holder upon, as
applicable, surrender of any stock certificates evidencing such shares of Pubco Shares, or to update the applicable book entry position
of such Holder so that it no longer is subject to such a restriction, and (iii) use commercially reasonable efforts to cooperate with
such Holder to have such Holder’s Pubco Shares transferred into a book-entry position at The Depository Trust Company, in each case,
subject to delivery of customary documentation, including any documentation required by such restrictive legend or book-entry notation.

 

Notwithstanding the foregoing,
the Company shall not be required to provide any documents or information to an Underwriter or other sales agent or placement agent if
such Underwriter or other sales agent or placement agent has not then been named with respect to the applicable Underwritten Offering
or other coordinated offering that is registered pursuant to a Registration Statement.

 

3.2              
Registration Expenses. The Registration Expenses of all Registrations shall be borne
by the Company. It is acknowledged by the Holders that the Holders selling any Registrable Securities in an offering shall bear all incremental
selling expenses relating to the sale of Registrable Securities, such as Underwriters’ or agents’ commissions and discounts,
brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,”
all reasonable fees and expenses of any legal counsel representing the Holders, in each case pro rata based on the number of Registrable
Securities that such Holders have sold in such Registration.

 

    14

     

    

 

3.3              
Requirements for Participation in Registration Statement Underwritten Offerings. Notwithstanding
anything in this Agreement to the contrary, if any Holder does not provide the Company with its requested Holder Information, the Company
may exclude such Holder’s Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines,
based on the advice of counsel, that such information is necessary to effect the registration and such Holder continues thereafter to
withhold such information. No person may participate in any Underwritten Offering or other coordinated offering for equity securities
of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s
securities on the basis provided in any arrangements approved by the Company and (ii) completes and executes all customary questionnaires,
powers of attorney, indemnities, lock-up agreements, underwriting or other agreements and other customary documents as may be reasonably
required under the terms of such arrangements. The exclusion of a Holder’s Registrable Securities as a result of this Section 3.3
shall not affect the registration of the other Registrable Securities to be included in such Registration. 

 

3.4              
Suspension of Sales; Adverse Disclosure; Restrictions on Registration Rights.

 

3.4.1         
Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each
of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended
Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment
as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus
may be resumed.

 

3.4.2         
If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any
time would (a) require the Company to make an Adverse Disclosure, (b) require the inclusion in such Registration Statement of
financial statements that are unavailable to the Company for reasons beyond the Company’s control, or (c) in the good faith
judgment of the majority of the Board, be seriously detrimental to the Company and the majority of the Board concludes as a result that
it is essential to defer such filing, initial effectiveness or continued use at such time, the Company may, upon giving prompt written
notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for
the shortest period of time determined in good faith by the Company to be necessary for such purpose (any such period, a “Blackout
Period”); provided, that no Blackout Period shall exceed more than 60 consecutive days after the request of the Holders
is given. In the event the Company exercises its rights under this Section 3.4.2, the Holders agree to suspend, immediately
upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale
or offer to sell Registrable Securities.

 

3.4.3         
(a) During the period starting with the date 60 days prior to the Company’s good faith estimate of the date of the
filing of, and ending on a date 90 days after the effective date of, a Company-initiated Registration and provided that the Company continues
to actively employ, in good faith, all reasonable efforts to maintain the effectiveness of the applicable Shelf, or (b) if, pursuant to
Section 2.1.4, Holders have requested an Underwritten Shelf Takedown and the Company and such Holders are unable to obtain the
commitment of underwriters to firmly underwrite such offering, the Company may, upon giving prompt written notice of such action to the
Holders, delay any other registered offering pursuant to Sections 2.1.4 or 2.4.

 

    15

     

    

 

3.4.4         
The right to delay or suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to
Section 3.4.2 or a registered offering pursuant to Section 3.4.3 shall be exercised by the Company, in the aggregate, for
not more than 60 consecutive calendar days and not more than twice during any 12-month period.

 

3.5              
Reporting Obligations. As long as any Holder shall own Registrable Securities, the
Company, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in
respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant
to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings;
provided that any documents publicly filed or furnished with the Commission pursuant to the Electronic Data Gathering, Analysis
and Retrieval System shall be deemed to have been furnished or delivered to the Holders pursuant to this Section 3.5. The Company
further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to
time to enable such Holder to sell shares of Pubco Shares held by such Holder without registration under the Securities Act within the
limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule then in effect). Upon the
request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it
has complied with such requirements.

 

Article
IV

INDEMNIFICATION AND CONTRIBUTION

 

4.1              
Indemnification.

 

4.1.1         
The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors
and agents and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities
and out-of-pocket expenses (including without limitation reasonable outside attorneys’ fees) resulting from any untrue or alleged
untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof
or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing
to the Company by such Holder expressly for use therein, or any violation by the Company of the Securities Act or any rule or regulation
promulgated thereunder applicable to the Company and relating to action or inaction of the Company in connection therewith.

 

4.1.2         
In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder
shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with
any such Registration Statement or Prospectus (the “Holder Information”) and, to the extent permitted by law, shall
indemnify the Company, its directors, officers and agents and each person who controls the Company (within the meaning of the Securities
Act) against all losses, claims, damages, liabilities and out-of-pocket expenses (including without limitation reasonable outside attorneys’
fees) resulting from any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary
Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained
in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that
the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of
each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the
sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters,
their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent
as provided in the foregoing with respect to indemnification of the Company.

 

    16

     

    

 

4.1.3         
Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim
with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right
to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such
indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with
respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the
indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by
the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled
to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all
parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party
a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of a release from all liability in respect to such claim or litigation.

 

4.1.4         
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive
the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such
provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such
Holder’s indemnification is unavailable for any reason.

 

4.1.5         
If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient
to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and out-of-pocket expenses referred to herein,
then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and out-of-pocket expenses in such proportion as is appropriate to reflect
the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,
including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made
by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified
party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however,
that the liability of any Holder under this Section 4.1.5 shall be limited to the amount of the net proceeds received by such Holder
in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred
to above shall be deemed to include, subject to the limitations set forth in Sections 4.1.1, 4.1.2 and 4.1.3 above,
any legal or other fees, charges or out-of-pocket expenses reasonably incurred by such party in connection with any investigation or proceeding.
The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.1.5 were determined
by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred
to in this Section 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution pursuant to this Section 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.

 

    17

     

    

 

Article
V

MISCELLANEOUS

 

5.1              
Notices. All notices and other communications among the parties shall be in writing
and shall be deemed to have been duly given (i) when delivered in person, or (ii) when delivered by FedEx or other nationally recognized
overnight delivery service, in each case with a copy sent by e-mail to such Holder. Any notice or communication under this Agreement
must be addressed, if to the Company, to [ __ ], with a copy (which will not constitute notice) to Wilson Sonsini Goodrich & Rosati,
P.C., 1301 Avenue of the Americas, New York, NY 10019, Attn: Megan J. Baier and Michael Labriola, and if to any Holder, at such Holder’s
address and e-mail address as set forth in the Company’s books and records. Any Party may change the address to which notices,
requests, demands, claims and other communications hereunder are to be delivered by giving the Company notice in the manner herein set
forth.

 

5.2              
Assignment; No Third Party Beneficiaries.

 

5.2.1         
This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company
in whole or in part.

 

5.2.2         
A Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part,
to any person to whom it transfers Registrable Securities; provided that such Registrable Securities remain Registrable Securities following
such transfer and such person agrees to become bound by the terms and provisions of this Agreement.

 

5.2.3         
No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or
obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section
5.1 hereof, and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms
and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement).

 

5.2.4         
Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their
respective permitted successors and assigns. Any attempted assignment in violation of the terms of this Section 5.2 shall be null
and void, ab initio.

 

5.2.5         
This Agreement shall not confer any rights or benefits on any persons that are not parties
hereto, other than as expressly set forth in this Agreement and Section 5.2 hereof.

 

5.3              
Captions. The captions in this Agreement are for convenience only and shall not be
considered a part of or affect the construction or interpretation of any provision of this Agreement. 

 

5.4              
Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart
of a signature page to this Agreement by electronic means, including DocuSign, e-mail, or scanned pages shall be effective as delivery
of a manually executed counterpart to this Agreement, and such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

    18

     

    

 

5.5              
Severability. Whenever possible, each provision of this Agreement will be interpreted
in such a manner as to be effective and valid under applicable Law, but if any term or other provision of this Agreement is held to be
invalid, illegal or unenforceable under applicable Law, all other provisions of this Agreement shall remain in full force and effect
so long as the economic or legal substance of the Transactions is not affected in any manner materially adverse to any party. Upon such
determination that any term or other provision of this Agreement is invalid, illegal or unenforceable under applicable Law, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible
in an acceptable manner in order that the Transactions (including the Merger) are consummated as originally contemplated to the greatest
extent possible.

 

5.6              
Governing Law. This Agreement, the rights and duties of the parties hereto, any disputes
(whether in contract, tort or statute), and the legal relations between the parties arising hereunder shall be governed by and interpreted
and enforced in accordance with the laws of the State of New York without reference to its conflicts of law provisions.

 

5.7              
Jurisdiction. Each party hereto irrevocably and unconditionally submits to the exclusive
jurisdiction of the courts of the State of New York located in the City and County of New York or in the United States District Court
for the Southern District of New York, for the purposes of any proceeding, claim, demand, action or cause of action (a) arising under
this Agreement or (b) in any way connected with or related or incidental to the dealings of the parties hereto in respect of this Agreement
or any of the transactions contemplated hereby, and irrevocably and unconditionally waives any objection to the laying of venue of any
such proceeding in any such court, and further irrevocably and unconditionally waives and agrees not to plead or claim in any such court
that any such proceeding has been brought in an inconvenient forum. Each party hereby irrevocably and unconditionally waives, and agrees
not to assert, by way of motion or as a defense, counterclaim or otherwise, in any proceeding claim, demand, action or cause of action
against such party (i) arising under this Agreement or (ii) in any way connected with or related or incidental to the dealings of the
parties hereto in respect of this Agreement or any of the transactions contemplated hereby, (A) any claim that such party is not personally
subject to the jurisdiction of the courts as described in this Section 5.7 for any reason, (B) that such party or such party’s
property is exempt or immune from the jurisdiction of any such court or from any legal process commenced in such courts (whether through
service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and
(C) that (x) the proceeding, claim, demand, action or cause of action in any such court is brought against such party in an inconvenient
forum, (y) the venue of such proceeding, claim, demand, action or cause of action against such party is improper or (z) this Agreement,
or the subject matter hereof, may not be enforced against such party in or by such courts. Each party agrees that service of any process,
summons, notice or document by registered mail to such party’s respective address in accordance with Section XX shall be effective
service of process for any such proceeding, claim, demand, action or cause of action. Nothing in this Agreement will affect the right
of any party herein to serve process in any other manner permitted by applicable law.

 

5.8              
Remedies. The parties hereto agree that irreparable damage for which monetary damages,
even if available, would not be an adequate remedy, would occur in the event that the parties hereto do not perform their obligations
under the provisions of this Agreement in accordance with its specified terms or otherwise breach such provisions. The parties hereto
acknowledge and agree that (i) such parties shall be entitled to an injunction, specific performance, or other equitable relief, to prevent
breaches of this Agreement and to enforce specifically the terms and provisions hereof and thereof, without proof of damages and without
posting a bond, prior to the valid termination of this Agreement, this being in addition to any other remedy to which they are entitled
under this Agreement, and (ii) the right of specific enforcement is an integral part of the transactions contemplated hereby and without
that right, none of the parties hereto would have entered into this Agreement. Each party agrees that it will not oppose the granting
of specific performance and other equitable relief on the basis that the other parties hereto have an adequate remedy at law or that
an award of specific performance is not an appropriate remedy for any reason at law or equity. The parties acknowledge and agree that
any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
in accordance with this Section 5.8 shall not be required to provide any bond or other security in connection with any such injunction.

 

    19

     

    

 

5.9              
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AGREEMENT,
OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO IN RESPECT OF THIS AGREEMENT OR ANY OF
THE TRANSACTIONS RELATED HERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY OR OTHERWISE.
EACH OF THE PARTIES TO THIS AGREEMENT HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION WILL BE DECIDED
BY COURT TRIAL WITHOUT A JURY, AND THAT THE PARTIES TO THIS AGREEMENT MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE
OF THE CONSENT OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

 

5.10          
Amendments and Modifications. Upon the written consent of (a) the Company, (b)
Sponsor, (c) the Holders holding a majority of the voting power of the Registrable Securities then held by all Holders in the aggregate,
and (d) with respect to any waiver, amendment or modification that has a material adverse impact on a Major Legacy Equityholder, the
consent of such Major Legacy Equityholder, compliance with any of the provisions, covenants and conditions set forth in this Agreement
may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that in the event any
such waiver, amendment or modification would be disproportionate and adverse in any material respect to the material rights or obligations
hereunder of a Holder, the written consent of such Holder will also be required. No course of dealing between any Holder or the Company
and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under
this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any
rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies
hereunder or thereunder by such party.

 

5.11          
Termination of Existing Registration Rights. The registration rights granted under this Agreement shall supersede
any registration, qualification or similar rights of the Holders with respect to any shares or securities of SPAC or the Company granted
under any other agreement, and any of such preexisting registration, qualification or similar rights and such agreements shall be terminated
and of no further force and effect.

 

5.12          
Term. This Agreement shall be effective from and after the Closing Date and shall
terminate with respect to any Holder on the date that such Holder no longer holds any Registrable Securities. The provisions of Section
3.5 and Article IV shall survive any termination.

 

5.13          
Holder Information. Each Holder agrees, if requested in writing, to represent to the Company or such other requesting
Holder the total number of Registrable Securities held by such Holder in order for the Company or a requesting Holder to make determinations
hereunder.

 

[SIGNATURE PAGES FOLLOW]

 

    20

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	COMPANY:	 
	 	 	 
	 	Babylon Holdings Limited	 
	 	 	 
	 	By: 	/s/ Ali Parsadoust	 
	 	 	Name: Ali Parsadoust	 
	 	 	Title: Chief Executive Officer	 
	 	 	 
	 	 	 
	 	SPONSOR:	 
	 	 	 
	 	Alkuri Sponsors LLC	 
	 	 	 
	 	By: 	/s/ Richard Williams	 
	 	 	Name: Richard Williams	 
	 	 	Title: Authorized Signatory	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	ALP Partners Limited	 
	 	 	 
	 	By: 	/s/ Anthony Shield	 
	 	Name: Anthony Shield	 
	 	Title: Director	 

 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	Nedgroup Trust (Jersey) Limited as Trustee for the Parsa Family Foundation
	 	 	 
	 	By: 	/s/ Anthony Shield	 
	 	Name: Anthony Shield	 
	 	Title: Director	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	Dr Ali Parsadoust	 
	 	 	 
	 	By: 	/s/ Ali Parsadoust	 
	 	Name: Ali Parsadoust	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	Invik SA	 
	 	 	 
	 	By: 	/s/ Mikael Holmberg	 
	 	Name: Mikael Holmberg	 
	 	Title: Director	 
	 	 	 
	 	 	 
	 	By: 	/s/ Réjane Koczorowski	 
	 	Name: Réjane Koczorowski	 
	 	Title: Director	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	VNV (Cyprus) Limited	 
	 	 	 
	 	By: 	/s/ Boris Sinegubko	 
	 	Name: Boris Sinegubko	 
	 	Title: Director	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	HOLDERS:	 
	 	 	 
	 	The Public Investment Fund
	 	 	 
	 	By: 	/s/ His Excellency Mr. Yasir O. Al-Rumayyan	 
	 	Name: His Excellency Mr. Yasir O. Al-Rumayyan	 
	 	Title: Governor	 

 

 

 

 

 

[Signature Page to Registration Rights Agreement]

 

     

     

    

 

Schedule A

 

Legacy Equityholders

 

ALP Partners Limited

Parsa Family Foundation

Ali Parsadoust

Kinnevik Online AB

VNV (Cyprus) Limited

The Public Investment Fund (PIF)Exhibit
10.1

 

EXECUTIVE
CHAIRMAN AND CEO EMPLOYMENT AGREEMENT

 

THIS
EXECUTIVE CHAIRMAN AND CEO EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered on May 28, 2021 (“Execution
Date”), to be effective as of January 1, 2021 (“Effective Date”), between Blink Charging Co. a Nevada corporation,
(the “Company”), whose principal place of business is 605 Lincoln Road, 5th Floor, Miami Beach, Florida
33140 and Michael D. Farkas an individual (the “Farkas”), whose address is 5005 Lakeview Drive, Miami Beach, Florida,
33139. Farkas and the Company may hereinafter be referred individually as a “Party” and collectively as the “Parties.”

 

RECITALS

 

A.       The
Company, through its Affiliates and subsidiaries, sells, installs, and maintains electric vehicle charging stations located on municipal
or privately owned real property within designated areas throughout the United States and abroad (the “Business”).

 

B.       Farkas
is the founder of the Company and its current CEO and Executive Chairman, additionally, Farkas is an individual with extensive experience
in the EV charging industry and the Company wishes to extend this offer of continued employment to Farkas to extend his tenure as the
Company’s CEO and Executive Chairman.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein made, the Company and the Farkas hereby agree as follows:

 

1.       
EMPLOYMENT. The Company hereby agrees to continue its employment of Farkas and Farkas hereby accepts such continued employment
in his capacity as CEO and Executive Chairman, reporting directly to the Company’s board of directors (the “Board”)
upon the terms and conditions hereinafter set forth. The Company also may direct Farkas to perform such duties for other entities that
are now or may in the future be affiliated with the Company and its Affiliates, subject to the limitation that Farkas’s overall
time commitment is comparable to his current time commitment to the Company. Farkas shall serve the Company and the Affiliates diligently
and to the best of his ability. Farkas agrees during the Term (as hereinafter defined) of this Agreement to devote his full-time business
efforts, attention, energy and skill to the performance of his employment to furthering the interest of the Company and the Affiliates.
During the Term (including any renewals thereof) as defined herein, Farkas shall have such duties and responsibilities commensurate with
his position. For purposes of this Agreement, “Affiliate” with respect to either Party, shall mean any entity which
directly or indirectly controls or is controlled by, or is under common control with that Party. Farkas’s principal work location
shall be Miami-Dade County, Florida or such other location as mutually agreed to by the Parties in writing. Without limiting the generality
of the foregoing, with the exception of the entities and activities as set forth in Schedule “B” which are excluded from
this restriction, Farkas shall not, without the written approval of the Board, (i) serve as or be a consultant to or employee, officer,
agent or director of any Company, partnership or other entity other than the Company (other than civic, charitable, or other public service
organizations) or (ii) have more than a ten percent (10%) ownership interest in any enterprise other than the Company if such ownership
interest would reasonably be expected to have a material adverse effect upon the ability of Farkas to perform his duties hereunder.

 

2.       COMPENSATION/BENEFITS.
The terms of this Section 2 shall be in effect as of the Effective Date.

 

    	Page
                                            1 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

a.       Salary.
Company shall pay Farkas a base salary of Eight Hundred Thousand Dollars ($800,000) per year (the “Base Salary”),
less applicable taxes and withholdings, and paid in accordance with the Company’s payroll policies and procedures for all of the
Company’s employees. On the first anniversary of the Effective Date, the Base Salary shall be increased to $850,000, less applicable
taxes and withholdings. On the second anniversary of the Effective Date, the Base Salary shall be increased to $900,000, less applicable
taxes and withholdings.

 

b.       Performance
Bonus. Farkas and the Board will meet in good faith at the beginning of each calendar year to set Key Performance Indicators (“KPIs”)
for that calendar year. If Farkas achieves his established KPIs during the calendar year and each year thereafter, Farkas will receive
an bonus for the applicable calendar year (the “Annual Performance Bonus”). The Annual Performance Bonus shall have
a target award of 100% of his Base Salary (the “Target Award”), less applicable taxes and deductions, with Farkas
eligible to receive up to 200% of the Target Award based on the achievement of KPIs during the applicable year. In addition, the Company
may award Farkas an additional bonus in the form of cash and/or securities, at the discretion of the Board, or pursuant to one or more
written plans adopted by the Board for similarly situated employees. Any Annual Performance Bonus shall be payable no later than March
15 in the year following the applicable bonus year.

 

c.       Equity
Performance Award. Farkas will be entitled to receive annual Equity Awards with a target aggregate award value of One Million Dollars
($1,000,000) (the “Annual Equity Award”) under the Incentive Plan. The actual amount of the Equity Awards will be
decided based on the percentage of the KPIs which Farkas meets in the applicable year (the “Performance Grant”), with Farkas
eligible to receive up to 200% of the target aggregate award value based on the achievement of KPIs during the applicable year. The Board
shall determine the actual Equity Awards to be granted based on the percentage of the KPIs which Farkas meets in the applicable calendar
year. Any Performance Grant shall be granted no later than the end of the first quarter in the calendar year following the applicable
calendar/performance year, provided that on the applicable Performance Grant date, Farkas is still employed by the Company. Fifty percent
(50%) of the Performance Grant will be in the form of Restricted Common Stock (the “RCSs”) and the remaining fifty
percent (50%) of the Performance Grant will be in the form of options to purchase the Company’s common stock (the “Stock
Options”). Except as otherwise provided in Section 4(b) with respect to the Performance Options, all options granted to Farkas
under this Agreement shall be valid for a period of five (5) years. One-third (1/3rd) of the RCSs shall vest on the first
anniversary of the Performance Grant. The remaining two-thirds (2/3rd) shall vest in eight (8) equal
installments at the end of every calendar quarter within the two years following the first anniversary of the Performance Grant.
The number of Stock Options shall be calculated in accordance with the Company’s option valuation practices. One-third (1/3rd
) of the Options shall vest on the first (1st) anniversary of the Performance Grant. The remaining two-thirds (2/3rd)
shall vest in eight (8) equal installments at the end of every calendar quarter within the
two years following the first (1st ) anniversary of the Performance Grant. The RCS grant will include a cash payment
upon vesting to cover expected ordinary income tax charges and will be calculated at the highest individual personal income tax rate
(“Gross Up”). Notwithstanding the foregoing, the vesting schedule of the RCSs and the Stock Options granted pursuant
to each Annual Equity Award shall not be less favorable than the vesting schedule applicable to any equity award granted to a majority
of the other senior executives of the Company for the same performance year. The Parties agree that, for years 2022 or later, the Company
may transition to the use of KPIs where some or all of the KPIs span more than one performance year, and in such event, the Company and
Farkas agree to such modifications to his Equity Awards, consistent with the financial terms described in this paragraph that are needed
to implement the revised policy.

 

    	Page
                                            2 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

d.       Employee
Benefits. Farkas and his family shall be entitled to participate in all benefit programs of the Company currently existing or hereafter
made available to Farkas and/or other executive employees, including, but not limited to, pension and other retirement plans, including
any 401K Plan, group life insurance, dental insurance, medical insurance, sick leave, vacation and holidays at no cost to Farkas. Additionally,
Farkas will be entitled to a $2,000 per month car allowance.

 

e.       Key
Man Insurance. The Company may elect to obtain a Key Man term life insurance policy on Farkas, and the Company will be named the
payee/beneficiary on such policy.

 

f.       Paid
Time Off. The Company provides a flexible Paid Time Off (“PTO”) program that will allow Farkas to use PTO for absences
due to illness, vacation or personal need. The amount of PTO Farkas will be granted will be 30 days per calendar year. Upon the termination
of Farkas’s employment under this Agreement, for any reason, Farkas shall be entitled to compensation for any unused PTO.

 

g.       Business
Expense Reimbursement. Farkas shall be entitled to receive reimbursement for all reasonable, out-of-pocket expenses incurred and
approved by the Company.

 

h.       D&O
Insurance/Indemnification. The Company shall procure and keep in effect Director’s and Officer’s (“D&O”)
Liability insurance coverage (“D&O Coverage”) throughout the Term and any Renewal Term(s), and Farkas will be eligible
to receive all benefits provided thereunder, with the policy listing Farkas as an insured. Such D&O insurance shall be procured in
an amount not less than the current coverage amount in effect as of the execution of this Agreement, and in any event no less advantageous
than that which is in effect for other directors and officers of the Company. The Company further agrees to indemnify and hold harmless
Farkas (which shall include any of his legal representatives) to the fullest extent authorized by law, from and against any expenses
(including reasonable fees and costs of counsel, accountants and other experts), judgments, fines, liabilities, losses and amounts reasonably
incurred by Farkas in connection with any threatened, pending or completed action, suit, claim or proceeding (hereinafter, a “Proceeding”),
whether civil, criminal, administrative or investigative, by reason of the fact that Farkas is or was a director or officer of the Company,
or is or was serving at the request of the Company as a director, officer, employee, fiduciary or agent of another corporation, partnership,
joint venture, trust or other enterprise, and whether or not the cause of such Proceeding occurred before or after the date of this Agreement.
Farkas shall not settle any matter for which Farkas has sought or intends to seek indemnification hereunder without first attempting
to obtain any approval required with respect to such settlement by the insurance carrier of any applicable D&O Coverage. If Farkas
seeks such approval, but such approval is not granted by such insurance carrier, Farkas shall be entitled to indemnification from the
Company to the fullest extent provided by such D&O Coverage or to the fullest extent otherwise provided by this Agreement, whichever
shall be greater. The provision of D&O Coverage by an insurance carrier at the expense of the Company or the failure to so provide
D&O Coverage shall in no way limit or diminish the obligation of the Company to indemnify Farkas, which obligation shall be absolute,
provided that any amounts actually recovered by Farkas from the insurance carrier providing D&O Coverage shall be applied in reduction
of amounts otherwise owing by the Company by reason of its indemnification under this Agreement.

 

i.       Evergreen
Provision. Farkas and the Company expressly agree that the Evergreen Provision applicable to options/warrants granted to Farkas shall
continue to apply only to options/warrants granted to Farkas prior to the Effective date (and the reissuance of such options/warrants)
and that any options/warrants granted following the execution of this Agreement shall not be subject to the Evergreen provision.

 

    	Page
                                            3 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

3.       TERM.
The Term of employment hereunder will commence on the Effective Date and continue for a period of three (3) years unless notice of the
intent to terminate the Agreement is provided in writing by either Party to the other at least ninety (90) days prior to the end of the
Term. If neither Party provides notice of intent to terminate the Agreement at least ninety (90) days prior to the end of the Term or
any Renewal Term, the Term and any subsequent Renewal Term will automatically renew for successive one (1) year periods (each a “Renewal
Term”). For the purposes of the Sections discussing Severance below, a Termination of this Agreement less than ninety (90) days
prior to the end of the Term will be considered a Termination during the Renewal Term.

 

4.       PAYMENTS
UPON SIGNING.

 

a.       On
or before the first pay period following the Execution Date, the Company shall provide Farkas:

 

		(i)	a
                                                                                                                                                                                                                                      one-time lump sum payment, less applicable taxes and withholding, of $[TBD], equaling
                                                                                                                                                                                                                                      $320,000 then multiplied by a fraction whose numerator is equal to the number of days between June 14, 2020 and the Execution Date
                                                                                                                                                                                                                                      and whose denominator is 365, representing the difference between Farkas’s prior base compensation and the new base
                                                                                                                                                                                                                                      compensation provided under this Agreement, but minus the bonus in the amount of $294,575.34 paid to Farkas as an advance
                                                                                                                                                                                                                                      payment;

 

		(ii)	a
                                            one-time lump sum payment for the Annual Performance Bonus for the year 2020, in the total
                                            amount of $[TBD], less applicable taxes and withholdings, but minus the bonus in the
                                            amount of $500,000 that has already been paid to Farkas as an advance payment; and

 

		(iii)	a
one-time grant of the Equity Performance Grant (the “Execution Grant”) for the year 2020, in the total value of $[TBD]
represented by RCSs and Stock Options less: (i) the number of RCSs
that have been issued to Farkas in advance (7,349 RCSs), and (ii) the number of Stock Options that have been granted to Farkas in advance
(23,862 Stock Options).

 

The
payments and Execution Grant provided pursuant to this Section 4 shall be in full satisfaction of any salary, bonuses, Equity Awards,
or other payments accrued by the Company and/or owed to Farkas prior to the Execution Date.

 

b.       One-Time
Potential Performance Bonus. Upon the execution of this Agreement, the Company shall grant Farkas Stock Options with a total value
of $25 Million and a four (4) year term (the “Performance Options”). The Performance Options shall vest if the Company’s
stock price at the NASDAQ exchange reaches and remains on average for a period of twenty consecutive market days at a closing price of
$90 per share (the “Vesting Condition”) during the term of the option. The number of options to be granted shall be determined
based upon number of Stock Options necessary to create a total value of $25 Million if the Vesting Conditions is met taking into account
the stock price upon the Execution Date. For instance, if the stock price is $40 upon the Execution Date, Farkas shall be granted 500,000
unvested Stock Options which shall vest upon the Vesting Condition. In the event a Change of Control (defined below), or a termination
of employment pursuant to Section 5(a), the Performance Options shall continue to vest during the term of the option, even if the Vesting
Condition is met following a Change in Control.

 

    	Page
                                            4 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

5.       TERMINATION
AND SEVERANCE. Upon Farkas’s termination of employment for any reason, Farkas shall be entitled to receive any unpaid Base
Salary through the date of termination, all earned but unpaid Bonuses and any vested benefits in accordance with the terms of the Company’s
employee benefit plans (the “Accrued Obligations”). Farkas shall not otherwise be entitled to any further compensation or
benefits by reason of any such termination, except as provided herein and below:

 

a.       Termination
without Cause; termination for death or disability; or Resignation by Farkas for Good Reason. In consideration of Farkas entering
into the Restrictive Covenants set forth in Section 5 of this Agreement, if the Company (or any parent or subsidiary or successor of
the Company) terminates Farkas’s employment with the Company without Cause, if this Agreement is terminated due to Farkas’s
death or disability, or Farkas resigns for Good Reason then, subject to Section 6, in addition to being paid the Base Salary for the
remainder of the Term or Renewal Term (as applicable) of this Agreement, Farkas will be entitled to the following:

 

(i)       A
lump sum payment equal to 100% of the Target Award for the year of termination, which shall be prorated for the number of days Farkas
was employed during such year;

 

(ii)       a
lump sum payment equal to 2.6 times the sum of (A) Farkas’s then current Base Salary (or if greater, his Base Salary at any time
during the prior two (2) year period); (B) one hundred percent (100%) of the Target Award of Annual Performance Bonus (the bonus in Section
2(b) herein; and (C) one hundred percent (100%) of the target Equity Performance Award (the bonus in Section 2(c) herein;

 

(iii)       
provided that Farkas timely elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”) for Farkas and Farkas’s eligible dependents, reimbursement from the Company for the COBRA premiums
for such coverage (at the coverage levels in effect immediately prior to such termination) for up to twenty-four (24) months following
the termination date, as long as Farkas remains eligible for COBRA; provided, however, that if the Company determines that reimbursed
COBRA premiums would be deemed to be discriminatory or to otherwise violate the then-applicable provisions of the Patient Protection
and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, and the guidance and regulations issued thereunder,
the Company will in lieu thereof provide to Farkas a taxable monthly payment, payable on the last day of a given month, in an amount
equal to the monthly COBRA premium that Farkas would be required to pay to continue Farkas’s group health coverage in effect on
the termination of employment date (which amount will be based on the premium for the first month of COBRA coverage), which such payments
will commence on the month following Farkas’s termination from employment and will end on the earlier of (x) the date upon which
Farkas obtains other employment or (y) the date the Company has paid an amount equal to twenty-four (24) payments; and

 

(iv)       all
issued and unvested equity awards, except the Performance Bonus under Section 4(d), shall immediately vest; provided, however, the Performance
Bonus shall remain outstanding and shall vest if the Vesting Condition is actually met.

 

    	Page
                                            5 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

Farkas
shall receive the payments and other consideration under this Section 5(a) only upon Farkas’s execution and delivery of a customary
general release (that is not revoked by him under applicable law) of the Company, its parents, subsidiaries and affiliates and each of
their respective officers, directors, employees, agents, successors and assigns, provided that such general release will not release
the Company from any obligation towards Farkas under the Commission Sales Agreement dated November 17, 2009 and any amendments thereto
(collectively, the “Commission Sales Agreement”), once it is no longer suspended.

 

All
payments under this Section 5(a) shall be made within thirty (30) days following termination of Farkas’s employment; provided,
however, that to the extent required by Code Section 409A (as defined below), if the thirty (30) day period begins in one calendar year
and ends in the second calendar year, all payments will be made in the second calendar year.

 

For
the purposes of this Agreement, “Good Reason” means Farkas’s resignation within thirty (30) days following the expiration
of any Company cure period (discussed below) following the occurrence of one or more of the following, without Farkas’s express
written consent: (i) any material and adverse change in Farkas’s position with the Company; (ii) any material diminution in Farkas’s
title, duties, responsibilities and reporting relationships; (iii) a material reduction in Farkas’s Base Salary; (iv) a relocation
of Farkas’s principal Company office to a location more than thirty (30) miles from its current location; or (v) any material breach
by the Company of this Agreement; provided, however, that with respect to any Good Reason termination, the Board will be given
not less than thirty (30) days’ written notice by Farkas (within ninety (90) days of the occurrence of the event constituting Good
Reason) of Farkas’s intention to terminate Farkas’s employment for Good Reason, such notice to state in detail the particular
act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Good Reason is based, and
such termination shall be effective at the expiration of such thirty (30) day notice period only if the Company has not fully cured such
act or acts or failure or failures to act that give rise to Good Reason during such period or if such violation is not reasonably curable
within such thirty (30) day period, but the Company is proceeding diligently and in good faith to cure such violation, such longer period
as is reasonably needed by Company, not to exceed forty (45) days following the date of such notice.

 

b.       Termination
for Cause; or Resignation without Good Reason. If Farkas’s employment with the Company (or successor of the Company) terminates
voluntarily by Farkas (except upon resignation for Good Reason), or for Cause by the Company, then Farkas shall receive the Accrued Obligations
and (i) all vesting will terminate immediately with respect to Farkas’s outstanding Equity Awards and (ii) all payments of compensation
by the Company to Farkas hereunder will terminate immediately (except as to amounts already earned). Farkas’s death or disability
shall be considered as Resignation for Good Reason. For purposes of this Agreement, “Cause” is defined as (i) a conviction
of, or pleading nolo contendere or guilty to, or committing a felony against the Company by Farkas; (ii) engaging in misconduct resulting
in significant economic or reputational harm (other than immaterial harm) to the Company by Farkas; (iii) any act of fraud, embezzlement,
or misappropriation by Farkas that is materially injurious to the Company; (iv) repeated and material failure by Farkas to substantially
perform his principal job duties and lawful obligations (for reasons other than disability or death); provided, that, the failure
of Farkas or the Company to achieve certain results, such as the Company’s business plan, in and of itself, would not constitute
“Cause”; (v) material failure or willful refusal by Farkas to materially comply with reasonable and lawful policies, standards,
instructions or regulations established by the Company; provided, that, the failure of Farkas or the Company to achieve certain
results, such as the Company’s business plan, in and of itself, would not constitute “Cause”; or (vi) the material
breach by Farkas of this Agreement or any other material written agreement entered into between Farkas and the Company. The Company shall
not terminate Farkas for Cause (except pursuant to clause “(i)” or clause “(ii)” above) without first providing
Farkas with written notice of the acts or omissions constituting the grounds for such termination and allowing for the expiration of
a cure period of thirty (30) days following the date of such notice, or if such violation is not reasonably curable within such thirty
(30) day period but Farkas is proceeding diligently and in good faith to cure such violation, such longer period as is reasonably needed
by Farkas, not to exceed forty-five (45) days following the date of such notice. For purposes of this definition, an act or omission
is “willful” if it was knowingly done, or knowingly omitted by Farkas and Farkas knew or a reasonable person would have known
that such act or omission was contrary to the best interests of the Company. Any act, or failure to act, done based on or in accordance
with specific instructions pursuant to a resolution duly and lawfully adopted by the Company’s board of directors or based upon
the advice of counsel shall be conclusively presumed to be done, or omitted to be done, by Farkas in the best interests of the Company.

 

    	Page
                                            6 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

c.       Change
of Control. If the Company (or any parent or subsidiary or successor of the Company) terminates Farkas’s employment with the
Company without Cause or Farkas resigns for Good Reason either (x) within nine (9) months prior to a period of time when the Company
is party to a fully executed letter of intent or a definitive corporate transaction agreement, the consummation of which would result
in a Change in Control (defined below) or (y) within eighteen months following a Change of Control, then Farkas shall receive the payments
and grants described in Sections 5(a) above, provided, however, the lump sum payment in 5(a)(i) above shall be equal to 3.5 times the
sum of (A) his then Base Salary; (B) the target Annual Performance Bonus; and (C) his Equity Performance Award (“Change of Control
Payment”). For purposes of this Agreement, “Change of Control” of the Company is defined as: (i) any “person”
(as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) is or becomes the “beneficial
owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing more than 50%
of the total voting power represented by the Company’s then outstanding voting securities; (ii) the date of the consummation of
a merger or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other
than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing
to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at
least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its
parent outstanding immediately after such merger or consolidation; or (iii) the date of the consummation of the sale or disposition by
the Company of all or substantially all the Company’s assets. Notwithstanding the foregoing provisions of this definition, a transaction
will not be deemed a Change of Control unless the transaction qualifies as a “change in control event” within the meaning
of Code Section 409A.

 

d.       No
Duty to Mitigate. Farkas will not be required to mitigate the amount of any payment contemplated by this Section 5, nor will any
earnings that Farkas may receive from any other source reduce any such payments under this Section 5.

 

6.       RESTRICTIVE
COVENANTS. Farkas acknowledges and agrees that (i) he has a major responsibility for the operation, development and growth of
the Company’s business; (ii) Farkas’s work for the Company will bring him into close contact with Confidential Information
(defined below) of the Company and its clients; and (iii) the agreements and covenants contained in this Section 6 are essential to protect
the legitimate business interests of the Company and that the Company will not enter into this Agreement but for such agreements and
covenants. Accordingly, Farkas covenants and agrees to the following:

 

    	Page
                                            7 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

		a.	Confidential
                                            Information

 

i.       Farkas
understands that during his employment, he may have access to unpublished and otherwise confidential information both of a technical
and non-technical nature, relating to the business of the Company or any of its parents, subsidiaries, divisions, affiliates (collectively,
“Affiliated Entities”), or clients, including without limitation: (1) trade secrets, private or secret processes, methods
and ideas, as they exist from time to time, patents and information concerning the Company’s services, business records and plans,
inventions, acquisition strategy, price structure and pricing, discounts, costs, computer programs and listings, source code and/or subject
code, copyright, trademark, proprietary information, formulae, protocols, forms, procedures, training methods, development/technical
information, know-how, show-how, new product and service development, advertising budgets, past, present or planned marketing, activities
and procedures, method for operating the Company, credit and financial data concerning the Company’s customers, marketing and (2)
advertising, promotional and sales strategies, sales presentations, research information, revenues, acquisitions, practices and plans
and information which is embodied in written or otherwise recorded form, and other information of a confidential nature not known publicly
or by other companies selling to the same markets and specifically including information which is mental, not physical (collectively,
the “Confidential Information”) which are valuable, special and unique assets of the Company, access to and knowledge
of which have been provided to the Farkas by virtue of its association with the Company.

 

ii.       Farkas
agree that he shall (1) hold in confidence and not disclose or make available to any third party any Confidential Information obtained
directly or constructively during his employment, unless done so within the course and scope of his employment with the Company for the
benefit of the Company or as authorized in writing by the Board; (2) exercise all reasonable efforts to prevent third parties from gaining
access to the Confidential Information; (3) not use, directly or indirectly the Confidential Information except in order to perform his
duties and responsibilities under this Agreement; (4) restrict the disclosure or availability of the Confidential Information to those
who have a need to know the information to achieve the purposes of this Agreement who have executed a confidentiality agreement with
regard to such Confidential Information; (4) not copy or modify any Confidential Information without prior written consent of the Board,
provided, however, that such limitation on copying or modification of any Confidential Information does not include any modifications
or copying which would otherwise prevent Farkas from performing his duties and responsibilities under this Agreement; and (5) take such
other protective measures as may be reasonably necessary to preserve the confidentiality of the Confidential Information.

 

    	Page
                                            8 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

iii.       Farkas
further agrees (1) that Farkas shall promptly disclose in writing to the Company all ideas, inventions, improvements and discoveries,
related to EV Charging, which may be conceived, made or acquired by Farkas as the direct or indirect result of the disclosure by the
Company of the Confidential Information to Farkas; (2) that all such ideas, inventions, improvements and discoveries, related to EV Charging,
conceived, made or acquired by Farkas, alone or with the assistance of others, relating to the Confidential Information in accordance
with the provisions hereof shall belong to the Company and that Farkas shall not acquire any intellectual property rights in the ideas
under this Agreement, except the limited right to use as set forth in this Agreement; (3) that Farkas shall assist in the preparation
and execution of all applications, assignments and other documents which the Company may deem necessary to obtain patents, copyrights
and the like in the United States and in jurisdictions foreign thereto, and to otherwise protect the Company. Notwithstanding the above,
Farkas is the sole owner of the “Parking Bumper Patent” and the invention and technology concerning mobile fueling truck
for EZfill. Additionally, upon commercialization of new inventions developed by Farkas, the Board will convene to discuss additional
bonuses relating to such inventions. Farkas acknowledges and agrees that any all materials and information created, developed, prepared
or conceived of by Farkas (whether individually or jointly with others) during and in connection with Employee’s employment with
Employer, whether created on, after or prior to the date of this Agreement, that (a) relates in any manner to the actual or demonstrably
anticipated business, research or development of Employer, or results from or is suggested by any task or duties assigned to Employee
or any work performed by Employee for or on behalf of Employer; and (b) is protectable by any form of intellectual property in any jurisdiction
and/or is Confidential Information at any time (“Work Product”). Farkas hereby acknowledges and agrees that, except as provided
in this Agreement: (i) as between the Company and Farkas, the Company is the exclusive owner of all Confidential Information; and (ii)
all Employee Work Product is owned exclusively by the Company. Farkas further acknowledges and agrees that whenever possible, any Work
Product subject to copyright protection constitutes “work made for hire” under the federal copyright laws (17 U.S.C. Section
101, as amended, or any successor statute).

 

iv.       Attached
as Exhibit “A” is a list entitled “List of Preexisting Intellectual Property Rights” listing all inventions
and information created, discovered or developed by Farkas, whether or not patentable or registrable under patent, copyright or similar
statutes, made or conceived or reduced to practice or learned by Farkas, outside of the scope of employment with the Company (“Prior
Inventions”), which belong in whole or in part to Farkas, and which are not being assigned by Farkas to the Company. Farkas represents
that Exhibits “A” and “B” are complete and contain no confidential or proprietary information belonging
to a person or entity other than Farkas. Farkas reserves the right to develop inventions in technologies outside of the scope of employment
with Company, and Company agrees that it does not have any ownership claim to any inventions developed by Farkas outside of the scope
of employment. Farkas agrees to negotiate in good faith to grant the Company a right of first refusal to use Farkas’ invention
listed in Exhibit “A”, based on terms and conditions offered by others in the industry, and subject to the Company
obtaining a bona fide valuation of the proper price of such a grant from a third party valuation company. Such agreement to negotiate
in good faith to grant the Company a right of first refusal does not include the technology listed in Exhibit “B”,
and the Company shall have no rights whatsoever in the technology listed in Exhibit “B”, for which Farkas shall have
the right to continue to develop technology and shall retain all ownership rights in such developments. The Company agrees that such
technology listed in Exhibit “B”, is outside of the scope of employment with the Company and Company has no rights
whatsoever in such developments.

 

v.       Excluded
from the Confidential Information, and therefore not subject to the provisions of this Agreement, shall be any information which Farkas
can show (1) at the time of disclosure, is in the public domain as evidenced by printed publications; (2) after the disclosure, enters
the public domain by way of printed publication through no fault of Farkas; (3) by written documentation was in his possession at the
time of disclosure and which was not acquired directly or indirectly from the Company; or (4) by written documentation was acquired,
after disclosure, from a third party who did not receive it from the Company, and who had the right to disclose the information without
any obligation to hold such information confidential. The foregoing exceptions shall apply only from and after the date that the information
becomes generally available to the public or is disclosed to Farkas by a third party, respectively. Specific information shall not be
deemed to be within the foregoing exceptions merely because it is embraced by more general information in the public domain. Additionally,
any combination of features shall not be deemed to be within the foregoing exceptions merely because individual features are in the public
domain. If Farkas intends to avail himself of any of the foregoing exceptions, Farkas shall notify the Company in writing of his intention
to do so and the basis for claiming the exception.

 

    	Page
                                            9 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

vi.       Upon
written request of the Company, Farkas shall return to the Company all written materials containing the Confidential Information. Farkas
also shall deliver to the Company written statements signed by Farkas certifying all materials have been returned within five (5) days
of receipt of the request to do so. Notwithstanding the foregoing, however, Farkas shall be permitted to disclose Confidential Information
as may be required by a subpoena or other governmental order, provided that he first notifies the Company of such subpoena, order or
other requirement and such that the Company has the opportunity to obtain a protective order or other appropriate remedy.

 

b.       Non-Solicitation.
During Farkas’s employment with the Company or its Affiliated Entities and for twelve (12) months following the termination thereof
for any reason (the “Restricted Period”), Farkas shall not shall not solicit any person or entity who is, or was at any time
within the previous twelve (12) months, a Customer (as defined below) of the Company or any of its Affiliated Entities to terminate or
reduce its business with the Company. Throughout the Restricted Period, Farkas shall not, directly or indirectly, employ or solicit for
employment, or otherwise contract for or hire, the services of any individual who is then an employee of or consultant to the Company
or any of its Affiliated Entities or who was an employee of the Company or any of its Affiliated Entities during the twelve (12) month
period preceding the termination of his employment. Throughout the Restricted Period, Farkas shall not take any action that could reasonably
be expected to have the effect of encouraging or inducing any employee, consultant, representative, officer, or director of the Company
or any of its Affiliated Entities to cease their relationship with the Company or any of its Affiliated Entities for any reason.

 

c.       Non-Competition.
Throughout the Restricted Period, Farkas shall not, within the Territory (defined below) directly or indirectly, own, manage, operate,
control, consult with, be employed by, participate in the ownership, management, operation or control of, or otherwise render services
to or engage in, any business engaged in or competitive with the businesses conducted by the Company or its Affiliated Entities. For
purposes of this Agreement, the term “Territory” shall mean throughout the area comprising the Company’s or any of
its Affiliated Entities, as applicable, market for its services and products within which area Farkas was materially involved during
the twelve (12) month period prior to the termination of Farkas’s employment. For purposes of this Agreement, the term “Customer(s)”
shall mean any individual, corporation, partnership, business or other entity, whether for-profit or not-for-profit, public, privately
held, or owned by the United States government that is a business entity or individual with whom the Company or any of its Affiliated
Entities has done business or with whom Farkas has actively negotiated with on behalf of the Company during the twelve (12) month period
preceding the termination of Farkas’s employment. Any activities, use or transactions relating to: (i) the Parking Bumper technology
and intellectual property rights (Patent Application 13/600,058), which Farkas may allow the Company to utilize, and (ii) the invention
and technology concerning mobile fueling truck for EZfill, are specifically excluded from this Non-Competition clause. The list of activities
enumerated in Exhibit “C” to this Agreement “Permitted Activities” also are specifically excluded from
this non-competition restriction.

 

d.       The
Parties agree that in the event a court determines the length of time, territory or activities prohibited under this Agreement are too
restrictive to be enforceable, the court may reduce the scope of the restriction to the extent necessary to make the restriction enforceable.

 

    	Page
                                            10 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

7.       AMENDMENTS
AND WAIVER. This Agreement shall not be modified or amended except by written agreement duly executed by the Parties hereto.
The waiver by either the Company or Farkas of a breach of any provision of this Agreement shall not operate as or be deemed a waiver
of any subsequent breach by either the Company or Farkas. Any waiver must be in writing.

 

8.       HEADINGS.
All sections and descriptive headings of this Agreement are inserted for convenience only and shall not affect the construction or interpretation
hereof.

 

9.       CODE
SECTION 409A COMPLIANCE. The intent of the Parties is that payments and benefits under this Agreement comply with, or be exempt
from, Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and guidance promulgated
thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be
interpreted and administered accordingly. A termination of employment shall not be deemed to have occurred for purposes of any provision
of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment that are considered
“nonqualified deferred compensation” under Code Section 409A unless such termination is also a “separation from service”
within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,”
“termination of employment” or like terms shall mean “separation from service.” With regard to any provision
herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right
to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses
eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement,
or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall not be violated without
regard to expenses reimbursed under any arrangement covered by Code Section 105(b) solely because such expenses are subject to a limit
related to the period the arrangement is in effect and (iii) such payments shall be made on or before the last day of Farkas’s
taxable year following the taxable year in which the expense occurred. For purposes of Code Section 409A, Farkas’s right to receive
any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.
Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., “within sixty (60)
days following the date of termination”), the actual date of payment within the specified period shall be within the sole discretion
of the Company. If Farkas is a specified employee within the meaning of Code Section 409A(a)(2)(B)(i) and would receive any payment sooner
than 6 months after Farkas’s “separation from service” that, absent the application of this Section 9, would be subject
to additional tax imposed pursuant to Code Section 409A as a result of such status as a specified employee, then such payment shall instead
be payable on the date that is the earliest of (i) 6 months after Farkas’s “separation from service,” or (ii) Farkas’s
death.

 

    	Page
                                            11 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

10.       SECTION
280G. In the event that any payments, distributions, benefits or entitlements of any type payable to Farkas (the “Total
Payments”) would (i) constitute “parachute payments” within the meaning of Section 280G of the Code (which will not
include any portion of payments allocated to the restrictive covenant provisions of Section 6 hereof that are classified as payments
of reasonable compensation for purposes of Section 280G of the Code), and (ii) but for this paragraph would be subject to the excise
tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Total Payments shall be either: (a) provided in full,
or (b) provided as to such lesser extent as would result in no portion of such Total Payments being subject to the Excise Tax, whichever
of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in Farkas’s
receipt on an after-tax basis of the greatest amount of the Total Payments, notwithstanding that all or some portion of the Total Payments
may be subject to the Excise Tax. Unless the Company and Farkas otherwise agree in writing, any determination required under this Section
10 shall be made in writing in good faith based on the advice of a nationally recognized accounting firm selected by the Company (with
approval of Farkas) (the “Accountants”). In the event of a reduction of benefits hereunder, benefits shall be reduced by
first reducing or eliminating the portion of the Total Payments that are payable in cash under Section 5 and then by reducing or eliminating
any amounts that are payable with respect to long-term incentives including any equity-based or equity-related awards (whether payable
in cash or in kind). For purposes of making the calculations required by this Section 10, the Accountants may make reasonable assumptions
and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the
Code, and other applicable legal authority. The Company and Farkas shall furnish to the Accountants such information and documents as
the Accountants may reasonably require to make a determination under this Section 10, and the Company shall bear the cost of all fees
the Accountants charge in connection with any calculations contemplated by this Section 10.

 

11.       COUNTERPARTS
AND ELECTRONIC TRANSMISSION. This Agreement may be executed in any number of counterparts and by electronic transmission, each
of which, when executed and delivered, shall be an original; but all counterparts shall together constitute one and the same instrument.

 

12.       ENTIRE
AGREEMENT. This Agreement constitutes the final understanding and agreement between the Parties with respect to the subject matter
hereof and supersedes all prior negotiations, understandings and agreements between the Parties related to subject matter hereof, whether
written or oral, including the 2010 employment agreement between Farkas and Car Charging Group, Inc., the December 2014 amendment to
that agreement, the July 2015 amendment to that agreement, and the October 2016 amendment to that agreement, except the Parties hereby
agree that the Commission Sales Agreement shall continue to be suspended and no payments shall be due thereunder for as long as Farkas
is a full-time employee of the Company that is due to be paid a monthly salary of at least $30,000.

 

13.       CONSTRUCTION.
This Agreement shall not be construed more strictly against one Party than the other, merely by virtue of the fact that it may have been
prepared by counsel for one of the Parties, it being recognized that both Company and Farkas have contributed substantially and materially
to the negotiation and preparation of this Agreement. In construing this Agreement, the singular shall include the plural and the plural
shall include the singular, and the use of any gender shall include every other and all genders.

 

14.       ENFORCEMENT.
If either Party breaches this Agreement, or any dispute arises out of or relating to this Agreement, the prevailing party shall be entitled
to its reasonable attorneys’ fees, paralegals’ fees and costs, at all levels, including appeal. The exclusive venue for any
dispute shall be in Miami Dade County, Florida and shall be governed by the laws of the State of Florida, without regard to its choice
of law principles, except where the application of federal law applies.

 

15.       SEVERABILITY.
Inapplicability or unenforceability of any provision of this Agreement shall not limit or impair the operation or validity of any other
provision of this Agreement or any such other instrument.

 

    	Page
                                            12 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

16.       ASSIGNMENT;
SUCCESSORS AND ASSIGNS, ETC. This Agreement is personal in nature and Farkas may not sell, transfer, assign, pledge or hypothecate
his rights, interests and obligations hereunder. Except as otherwise herein expressly provided, this Agreement shall be binding upon
and shall inure to the benefit of Farkas and his personal representatives and shall inure to the benefit of and be binding upon Farkas
and its successors and assigns, except that the Company may not assign this Agreement without Farkas’s prior written consent, except
to an acquirer of all or substantially all of the assets of the Company.

 

17.       NO
CONFLICTING OBLIGATIONS.
Farkas represents and warrants to the Company
that he is under no obligations or commitments,
whether contractual or otherwise, that are inconsistent with his obligations under this Agreement.
Farkas further represents and warrants to the Company
that he has returned all property and confidential information
belonging to any prior employer.

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.

 

	 	Blink
    Charging Co.
	 	 	 
	 	By:	/s/
    Brendan S. Jones
	 	Name:
    	Brendan
    S. Jones
	 	Its:
    	President
	 	 	 
	 	By:	/s/
    Michael Rama
	 	Name:
    	Michael
    Rama
	 	Its:	Chief
    Financial officer
	 	 	 
	 	By:	/s/
    Michael D. Farkas
	 	Name:	Michael
    D. Farkas

 

    	Page
                                            13 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

EXHIBIT
“A”

 

LIST
OF PREEXISTING INTELLECTUAL PROPERTY RIGHTS RELATED TO BLINK

 

	Unregistered
    Intellectual Property
	Title	Brief
    Description	Date
    of [Creation/[ or ]Invention]

 

Registered
Intellectual Property

 

	Jurisdiction	 	Name
    or Title	 	Status
    (Pending or Registered)	 	Registration
    or Application Serial Number	 	Registration
                                            or

    Application
    Date

	United
    States	 	Parking
    Lot Bumper Inductive Charger with Automatic Payment Processing	 	Registered

     
	 	United
                                            States Patent No. 10,836,269

     
	 	Issue
                                            Date Nov 17, 2020

     

 

*Anything
outside of scope of Farkas’ employment with the Company (outside of EV Charging).

 

__
No Pre-existing Intellectual Property Rights

__
Additional Sheets Attached

 

	Signature
    of Employee: 	/s/
    Michael D. Farkas	 
	Print
    Name of Employee: 	Michael
    D. Farkas	 
	Date:	May
    28, 2019	 

 

    	Page
                                            14 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

EXHIBIT
“B”

 

LIST
OF PREEXISTING INTELLECTUAL PROPERTY RIGHTS NOT RELATED TO BLINK

 

	Unregistered
    Intellectual Property
	Title	Brief
    Description	Date
    of [Creation/[ or ]Invention]
	EZfill’s
    new mobile truck fueling	Invention
    and technology concerning mobile fueling truck for EZfill	Work
    in Progress

 

Registered
Intellectual Property

 

	Jurisdiction	 	Name
    or Title	 	Status
    (Pending or Registered)	 	Registration
    or Application Serial Number	 	Registration
                                            or

    Application
    Date

	 	 	 	 	 	 	 	 	 

 

__
No Pre-existing Intellectual Property Rights

__
Additional Sheets Attached

 

	Signature
    of Employee: 	/s/
    Michael D. Farkas	 
	Print
    Name of Employee: 	Michael
    D. Farkas	 
	Date:	May
    28, 2021	 

 

    	Page
                                            15 of
                                            16	 	Initials
                                            _________  __________

    	 

    

 

EXHIBIT
“C”

 

PERMITTED
ACTIVITIES OF FARKAS 

 

		1.	LIST
                                            of Positions/Entities

 

CEO
of Balance Labs, Inc., and the performance of the duties of such position

CEO
of the Farkas Group, Inc., and the performance of the duties of such position

10%+
shareholder in EzFill Holdings Inc.

10%+
shareholder in Ariel Group, Inc.

Member
Manager of SIF Energy, LLC, and the performance of the duties of such position

Member
Manger of SIF Health, LLC, and the performance of the duties of such position

 

		2.	Together
                                            with such future non-full time positions as Farkas may hold in the entities listed above.

 

    	Page
                                            16 of
                                            16	 	Initials
                                            _________  __________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]